The Subcommittee on Health held a markup on Tuesday, December 10, 2013, at 2:00 p.m. in 2322 Rayburn House Office Building. The Subcommittee considered the following: • H.R. 3527, “Poison Center Network Act of 2013”; • H.R. 1098, “Traumatic Brain Injury Reauthorization Act;” and, • H.R. 1281, “Newborn Screening Saves Lives Reauthorization Act...
Full Committee Markup of "H.R. 3527, H.R. 1098, H.R. 724, H.R. 3683, H.R. 3675, and H.R. 3674" (December 10-11, 2013)
The Energy and Commerce Committee held a markup beginning on Tuesday, December 10, 2013. The Committee considered the following: • H.R. 3527, Poison Center Network Act of 2013; • H.R. 1098, Traumatic Brain Injury Reauthorization Act; • H.R. 724, a bill to amend the Clean Air Act to remove the requirement for dealer certification of new light-duty motor vehicles; • H...
Today Energy and Commerce Committee Ranking Member Henry A. Waxman released the following statement on the oral arguments before the Supreme Court on the Environmental Protection Agency’s (EPA) cross-state air pollution rule:
Hearing on “Evaluating the Role of FERC in a Changing Energy Landscape,” Subcommittee on Energy and Power (December 5, 2013)
The Subcommittee on Energy and Power held a hearing on Thursday, December 5, 2013, at 9:30 a.m. in 2123 Rayburn House Office Building. The hearing was titled “Evaluating the Role of FERC in a Changing Energy Landscape.”
Hearing on “Medicare Advantage: What Beneficiaries Should Expect Under the President’s Health Care Plan,” Subcommittee on Health (December 4, 2013)
The Subcommittee on Health held a hearing on Wednesday, December 4, 2013, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing was titled “Medicare Advantage: What Beneficiaries Should Expect Under the President’s Health Care Plan.”
Hearing on “The FTC at 100: Where Do We Go From Here?” Subcommittee on Commerce, Manufacturing, and Trade (December 3, 2013)
The Subcommittee on Commerce, Manufacturing, and Trade hearing scheduled for Thursday, October 24, 2013, was held Tuesday, December 3, 2013, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing was titled “The FTC at 100: Where Do We Go From Here?”
On December 2, 2013, H.R. 3588 was considered under suspension of the rules and passed the House by a roll call vote of 384 - 0.
H.R. 3204, the "Drug Quality and Security Act," helps ensure the safety of compounded drugs and our nation’s pharmaceutical supply chain. The legislation introduced by Committee Chairman Upton and cosponsored by Committee members Reps. Waxman, Pitts, Pallone, Murphy, Dingell, Latta, DeGette, Griffith, Green, and Matheson, reflects a bipartisan, bicameral effort to...
S. 252, the ‘‘Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early (PREEMIE) Reauthorization Act’’
S. 252, as amended, is bipartisan and bicameral legislation comprised of the authorization or reauthorization of three different, yet pertinent health programs. Title One of the bill reauthorizes and improves the PREEMIE Act. This title reauthorizes the Centers for Disease Control and Prevention research, surveillance, and prevention activities. It also extends provider...
Although it is the stated goal of H.R. 1900 to provide for “the timely consideration” of applications for natural gas pipeline projects, the legislative record clearly demonstrates that H.R. 1900 would disrupt the Federal Energy Regulatory Commission’s (FERC) existing permitting process, which gets natural gas pipelines permitted in a timely manner. This bill would...